Wei‐Hua Yan

3.4k total citations
100 papers, 2.6k citations indexed

About

Wei‐Hua Yan is a scholar working on Immunology, Reproductive Medicine and Agronomy and Crop Science. According to data from OpenAlex, Wei‐Hua Yan has authored 100 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Immunology, 24 papers in Reproductive Medicine and 22 papers in Agronomy and Crop Science. Recurrent topics in Wei‐Hua Yan's work include Reproductive System and Pregnancy (61 papers), Reproductive Physiology in Livestock (22 papers) and Endometriosis Research and Treatment (20 papers). Wei‐Hua Yan is often cited by papers focused on Reproductive System and Pregnancy (61 papers), Reproductive Physiology in Livestock (22 papers) and Endometriosis Research and Treatment (20 papers). Wei‐Hua Yan collaborates with scholars based in China, United States and Japan. Wei‐Hua Yan's co-authors include Aifen Lin, Dan‐Ping Xu, Huihui Xu, Yanyun Ruan, Heping Xu, J.‐G. Zhang, Xia Zhang, Min Zhu, Wenjun Zhou and Xuan-Yu Chen and has published in prestigious journals such as Scientific Reports, ACS Applied Materials & Interfaces and The Journal of Infectious Diseases.

In The Last Decade

Wei‐Hua Yan

100 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Hua Yan China 33 2.0k 656 507 437 391 100 2.6k
Aifen Lin China 33 1.8k 0.9× 601 0.9× 469 0.9× 432 1.0× 352 0.9× 93 2.5k
Catherine Menier France 30 3.4k 1.7× 1.2k 1.8× 1.2k 2.4× 221 0.5× 820 2.1× 42 3.7k
Akiko Ishitani Japan 22 3.3k 1.6× 628 1.0× 788 1.6× 317 0.7× 540 1.4× 36 3.5k
Philippe Le Bouteiller France 38 3.5k 1.8× 999 1.5× 1.2k 2.3× 227 0.5× 593 1.5× 80 3.8k
Ni Lee United States 13 2.7k 1.3× 297 0.5× 369 0.7× 312 0.7× 263 0.7× 14 2.8k
Manuel Llano Spain 14 2.4k 1.2× 227 0.3× 239 0.5× 445 1.0× 180 0.5× 24 2.7k
Renata Toscano Simões Brazil 18 695 0.4× 165 0.3× 226 0.4× 127 0.3× 186 0.5× 46 992
Gisela Dallenbach-Hellweg Germany 22 417 0.2× 586 0.9× 248 0.5× 371 0.8× 55 0.1× 95 2.2k
Arend Mulder Netherlands 38 3.3k 1.7× 96 0.1× 275 0.5× 1.1k 2.4× 27 0.1× 129 5.0k
Lewis Perrin Australia 25 198 0.1× 893 1.4× 235 0.5× 305 0.7× 12 0.0× 77 2.0k

Countries citing papers authored by Wei‐Hua Yan

Since Specialization
Citations

This map shows the geographic impact of Wei‐Hua Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Hua Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Hua Yan more than expected).

Fields of papers citing papers by Wei‐Hua Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Hua Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Hua Yan. The network helps show where Wei‐Hua Yan may publish in the future.

Co-authorship network of co-authors of Wei‐Hua Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Hua Yan. A scholar is included among the top collaborators of Wei‐Hua Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Hua Yan. Wei‐Hua Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Dantong, Wei‐Hua Yan, Jingjuan Zhu, et al.. (2022). Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification. Technology in Cancer Research & Treatment. 21. 2213870302–2213870302. 5 indexed citations
2.
Han, Qiu-Yue, Xia Zhang, Jiangang Zhang, et al.. (2022). Pre-operative neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with gastric cancer. International Immunopharmacology. 113(Pt A). 109371–109371. 13 indexed citations
3.
Chen, Yuxin, Qiu-Yue Han, Wenjun Zhou, et al.. (2021). Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer. Frontiers in Immunology. 12. 679090–679090. 30 indexed citations
4.
Xu, Huihui, Jun Gan, Dan‐Ping Xu, Lu Li, & Wei‐Hua Yan. (2021). Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers. Frontiers in Immunology. 12. 614773–614773. 13 indexed citations
5.
Sun, Dantong, Wei‐Hua Yan, Hua Zhu, Qiaoling Liu, & Helei Hou. (2020). Case Report: Primary and Acquired Resistance Mechanisms of Nimotuzumab in Advanced Esophageal Squamous Cell Carcinoma Revealed by Targeted Sequencing. Frontiers in Oncology. 10. 574523–574523. 5 indexed citations
6.
Zhang, Ruili, et al.. (2019). Expression and clinical significance of sHLA-G in plasma exosome in patients with colorectal cancer. Zhonghua jianyan yixue zazhi. 42(5). 347–353. 3 indexed citations
7.
Lin, Aifen, et al.. (2019). Prognostic and Risk Stratification Value of Lesion MACC1 Expression in Colorectal Cancer Patients. Frontiers in Oncology. 9. 28–28. 8 indexed citations
8.
Zheng, Shu-Guang, et al.. (2017). Henoch-Schönlein Purpura With Testicular Necrosis: Sonographic Findings at the Onset, During Treatment, and at Follow-up. Urology. 107. 223–225. 7 indexed citations
9.
Xu, Dan‐Ping, et al.. (2017). HLA-G 14 bp insertion/deletion polymorphism is a prognostic factor for non-small-cell lung cancer. Zhonghua weishengwuxue he mianyixue zazhi. 37(5). 361–368. 1 indexed citations
10.
Hou, Helei, Xiaonan Yang, Jinping Zhang, et al.. (2017). Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay. Scientific Reports. 7(1). 14605–14605. 21 indexed citations
11.
Lü, Shiming, Xu-ming Bian, Wang He, et al.. (2016). A multicenter study of fetal chromosomal abnormalities in Chinese women of advanced maternal age. Taiwanese Journal of Obstetrics and Gynecology. 55(3). 379–384. 30 indexed citations
12.
Ruan, Yanyun, et al.. (2016). Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer. Human Immunology. 77(4). 317–324. 24 indexed citations
13.
Zhang, Xia, Jiangang Zhang, Wenjun Zhou, et al.. (2012). Biobanking of Fresh-frozen Human Colon Tissues: Impact of Tissue Ex-vivo Ischemia Times and Storage Periods on RNA Quality. Annals of Surgical Oncology. 20(5). 1737–1744. 57 indexed citations
14.
Lin, Aifen, Huihui Xu, Dan‐Ping Xu, et al.. (2012). Multiple steps of HLA-G in ovarian carcinoma metastasis: Alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression. Human Immunology. 74(4). 439–446. 45 indexed citations
15.
Yan, Wei‐Hua. (2011). HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy. Endocrine Metabolic & Immune Disorders - Drug Targets. 11(1). 76–89. 50 indexed citations
16.
Xu, Dan‐Ping, et al.. (2011). Elevation of plasma soluble human leukocyte antigen–G in patients with chronic hepatitis C virus infection. Human Immunology. 72(5). 406–411. 38 indexed citations
17.
Gan, Lixia, et al.. (2010). Polymorphism of human CD1a, CD1d, and CD1e in exon 2 in Chinese Han and She ethnic populations. Tissue Antigens. 75(6). 691–695. 8 indexed citations
18.
Lin, Aifen, Chengsong Zhu, J.‐G. Zhang, et al.. (2009). Clinical relevance and functional implications for human leucocyte antigen‐g expression in non‐small‐cell lung cancer. Journal of Cellular and Molecular Medicine. 14(9). 2318–2329. 57 indexed citations
19.
Yan, Wei‐Hua, et al.. (2007). Possible Roles of KIR2DL4 Expression on uNK Cells in Human Pregnancy. American Journal of Reproductive Immunology. 57(4). 233–242. 50 indexed citations
20.
Lin, Aifen, Wei‐Hua Yan, Heping Xu, et al.. (2007). HLA-G expression in human ovarian carcinoma counteracts NK cell function. Annals of Oncology. 18(11). 1804–1809. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aifen Lin Breakdown of academic impact, for papers by Catherine Menier Breakdown of academic impact, for papers by Akiko Ishitani Breakdown of academic impact, for papers by Philippe Le Bouteiller Breakdown of academic impact, for papers by Ni Lee Breakdown of academic impact, for papers by Manuel Llano Breakdown of academic impact, for papers by Renata Toscano Simões Breakdown of academic impact, for papers by Gisela Dallenbach-Hellweg Breakdown of academic impact, for papers by Arend Mulder Breakdown of academic impact, for papers by Lewis Perrin
Rankless by CCL
2026